Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 3.05 USD -3.17% Market Closed
Market Cap: 454.5m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xeris Biopharma Holdings Inc
Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Long-Term Debt
$230.5m
CAGR 3-Years
38%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Long-Term Debt
$31.3B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Long-Term Debt
$48.7B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
21%
Pfizer Inc
NYSE:PFE
Long-Term Debt
$57.5B
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Long-Term Debt
$35B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
7%
Eli Lilly and Co
NYSE:LLY
Long-Term Debt
$29B
CAGR 3-Years
23%
CAGR 5-Years
16%
CAGR 10-Years
19%

See Also

What is Xeris Biopharma Holdings Inc's Long-Term Debt?
Long-Term Debt
230.5m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Long-Term Debt amounts to 230.5m USD.

What is Xeris Biopharma Holdings Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
51%

Over the last year, the Long-Term Debt growth was 22%. The average annual Long-Term Debt growth rates for Xeris Biopharma Holdings Inc have been 38% over the past three years , 51% over the past five years .

Back to Top